Primary biliary cirrhosis
|
0.480 |
GeneticVariation
|
disease |
GWASCAT |
POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.
|
30643196 |
2019 |
Primary biliary cirrhosis
|
0.480 |
Biomarker
|
disease |
BEFREE |
Furthermore, significantly increased TL1A had been detected in liver tissues and mononuclear cells of patients with primary biliary cirrhosis (PBC).
|
30906791 |
2019 |
Primary biliary cirrhosis
|
0.480 |
GeneticVariation
|
disease |
BEFREE |
Along with corroborating known PBC-associated loci (TNFSF15, HLA-DRA), risk haplotypes may potentially model cis-interactions that regulate gene expression.
|
29773854 |
2018 |
Primary biliary cirrhosis
|
0.480 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population.
|
28062665 |
2017 |
Primary biliary cirrhosis
|
0.480 |
GeneticVariation
|
disease |
BEFREE |
A previous genome-wide association study (GWAS) performed in 963 Japanese individuals (487 primary biliary cholangitis [PBC] cases and 476 healthy controls) identified TNFSF15 (rs4979462) and POU2AF1 (rs4938534) as strong susceptibility loci for PBC.
|
28062665 |
2017 |
Primary biliary cirrhosis
|
0.480 |
AlteredExpression
|
disease |
BEFREE |
In summary, we provide evidence that variance within TNFSF15 has the potential to affect cytokine expression across a range of tissues and thereby contribute to protection from infectious diseases such as leprosy, while increasing the risk of immune-mediated diseases including CD and PBC.
|
27507062 |
2016 |
Primary biliary cirrhosis
|
0.480 |
Biomarker
|
disease |
BEFREE |
TNFSF15 and ICOSLG-CXCR5 might constitute a shared pathogenic pathway in the development of PBC and CD in the Japanese population, whereas IL12B-STAT4-NFKB1 might constitute an opposite pathogenic pathway, reflecting the different balance between Th1 and Th17 in the two diseases.
|
26084578 |
2015 |
Primary biliary cirrhosis
|
0.480 |
GeneticVariation
|
disease |
BEFREE |
This study identified the causal variant for PBC susceptibility in the TNFSF15 locus and clarified its underlying molecular mechanism.
|
25899471 |
2015 |
Primary biliary cirrhosis
|
0.480 |
Biomarker
|
disease |
BEFREE |
This suggests that modulation of TL1A-DR3 interaction may be a potential therapeutic target in several autoimmune diseases, including IBD, RA, AS, and PBC.
|
24453414 |
2013 |
Primary biliary cirrhosis
|
0.480 |
SusceptibilityMutation
|
disease |
ORPHANET |
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.
|
23000144 |
2012 |
Primary biliary cirrhosis
|
0.480 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.
|
23000144 |
2012 |
Primary biliary cirrhosis
|
0.480 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.
|
23000144 |
2012 |
Primary biliary cirrhosis
|
0.480 |
GeneticVariation
|
disease |
BEFREE |
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.
|
23000144 |
2012 |